Aadi Bioscience Company Top Insiders

AADI Stock  USD 2.98  0.15  4.79%   
Aadi Bioscience's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Aadi Bioscience suggests that almost all insiders are panicking. Aadi Bioscience employs about 53 people. The company is managed by 9 executives with a total tenure of roughly 124 years, averaging almost 13.0 years of service per executive, having 5.89 employees per reported executive.

Aadi Bioscience's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-10-03David James LennonDisposed 9689 @ 1.94View
2024-09-03Neil DesaiDisposed 40000 @ 1.71View
2024-08-05Neil DesaiDisposed 5652 @ 1.34View
2024-08-01Neil DesaiDisposed 15415 @ 1.5View
2024-07-01Neil DesaiDisposed 31348 @ 1.45View
2024-05-01Neil DesaiDisposed 40000 @ 1.93View
2024-04-01Neil DesaiDisposed 17772 @ 2.31View
2024-03-04Neil DesaiDisposed 14964 @ 2.1View
2024-03-01Neil DesaiDisposed 27036 @ 1.97View
2024-02-01Neil DesaiDisposed 42000 @ 1.74View
Monitoring Aadi Bioscience's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Aadi Bioscience's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Aadi Bioscience's future performance. Based on our forecasts, it is anticipated that Aadi will maintain a workforce of under 50 employees by February 2025.
 
Covid

Aadi Bioscience Management Team Effectiveness

The company has return on total asset (ROA) of (0.3527) % which means that it has lost $0.3527 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6595) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.47. The current Return On Capital Employed is estimated to decrease to -0.64. As of now, Aadi Bioscience's Other Current Assets are increasing as compared to previous years. The Aadi Bioscience's current Non Current Assets Total is estimated to increase to about 9.5 M, while Intangible Assets are projected to decrease to under 3 M.
The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 32.5 M, while Net Loss is projected to decrease to (57.2 M).

Aadi Bioscience Workforce Comparison

Aadi Bioscience is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 3,891. Aadi Bioscience claims roughly 53.0 in number of employees contributing just under 2% to equities under Health Care industry.

Aadi Bioscience Profit Margins

The company has Profit Margin (PM) of (2.46) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.49) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.49.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.971.02
Notably Down
Pretty Stable

Aadi Bioscience Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aadi Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aadi Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Aadi Bioscience insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.5
1
2
 32,558 
 42,247 
2024-06-01
0.7
7
10
 320,824 
 377,500 
2024-03-01
2.25
9
4
 612,844 
 126,000 
2023-12-01
0.25
2
8
 522,558 
 126,000 
2023-06-01
0.5833
7
12
 269,530 
 126,000 
2021-12-01
1.0
1
1
 185,000 
 200,000 
2021-09-01
3.0
12
4
 5,719,785 
 63,440 
2020-12-01
0.5
1
2
 21,400 
 42,800 
2019-12-01
0.25
1
4
 44,300 
 263,300 
2019-06-01
0.8125
13
16
 2,138,000 
 1,370,000 
2019-03-01
3.0
12
4
 1,124,146 
 380,446 
2018-09-01
0.5
1
2
 268,987 
 1,608,826 
2018-06-01
5.0
15
3
 4,338,382 
 150,228 
2017-03-01
1.1429
8
7
 3,981,930 
 398,421 

Aadi Bioscience Notable Stakeholders

An Aadi Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aadi Bioscience often face trade-offs trying to please all of them. Aadi Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aadi Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David LennonCEO PresidentProfile
Scott CPATreasurer, CFOProfile
Neil DesaiPresident, FounderProfile
Raymond SteitzSenior OfficerProfile
Bryan BallChief OperationsProfile
Marcy GrahamSVP CommunicationsProfile
Stephen JDSenior CounselProfile
Brendan MBAChief OfficerProfile
MD FACPChief OfficerProfile

About Aadi Bioscience Management Performance

The success or failure of an entity such as Aadi Bioscience often depends on how effective the management is. Aadi Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aadi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aadi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.45)(0.47)
Return On Capital Employed(0.61)(0.64)
Return On Assets(0.45)(0.47)
Return On Equity(0.56)(0.59)

Aadi Bioscience Workforce Analysis

Traditionally, organizations such as Aadi Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aadi Bioscience within its industry.

Aadi Bioscience Manpower Efficiency

Return on Aadi Bioscience Manpower

Revenue Per Employee459.5K
Revenue Per Executive2.7M
Net Loss Per Employee1.2M
Net Loss Per Executive7.3M
Working Capital Per Employee1.9M
Working Capital Per Executive10.9M

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device